A modified DCF regimen as primary treatment for patients with metastatic gastric cancer

Koca D., Dogan E., Yardim H., Duzen O., Karaca S.

JOURNAL OF BUON, vol.18, no.2, pp.377-384, 2013 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 18 Issue: 2
  • Publication Date: 2013
  • Journal Name: JOURNAL OF BUON
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.377-384
  • Van Yüzüncü Yıl University Affiliated: Yes


Purpose: To retrospectively assess the efficacy and toxity of a modified docetaxel, cisplatin, fluorouracil (mDCF) regimen as primary treatment in patients with metastatic gastric cancer (MGC).